Stay updated on DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial page
- Check6 days agoChange DetectedThe page now includes a government funding lapse notice and a new revision label v3.4.1, replacing the previous v3.4.0.SummaryDifference0.4%

- Check13 days agoChange DetectedShow glossary added and minor wording/capitalization changes to update metadata (e.g., 'Last Update Submitted that Met QC Criteria' vs 'Last Update Submitted that met QC Criteria'; 'No FEAR Act Data' vs 'No FEAR Act data'), plus 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision tag updated: added v3.3.4 and removed v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check49 days agoChange DetectedA new Locations section is added, displaying Minnesota (Mayo Clinic, Rochester, MN). The page revision updated to v3.3.3 and the previous Minnesota Locations section and HHS Vulnerability Disclosure link were removed.SummaryDifference0.2%

- Check70 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2.SummaryDifference0.0%

- Check77 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1 on the page. This change represents a backend version update rather than any modification to the study content.SummaryDifference0.0%

Stay in the know with updates to DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial page.